Previous Close | 21.60 |
Open | 21.60 |
Bid | 25.80 |
Ask | 29.75 |
Strike | 105.00 |
Expire Date | 2024-06-21 |
Day's Range | 21.60 - 21.60 |
Contract Range | N/A |
Volume | |
Open Interest | 4 |
Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.
Q1 2024 Gilead Sciences Inc Earnings Call